寿康集团：Fortacin™╱Senstend™中国第三期随机临床试验取得十分优秀的成果
Apr 17, 2023 22:31 HKT |  |
|
壽康集團：Fortacin™╱Senstend™中國第三期隨機臨床試驗取得十分優秀的成果
Apr 17, 2023 22:30 HKT | |
|
Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China
Apr 17, 2023 22:29 HKT | |
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Apr 17, 2023 19:30 HKT |  |
|
亿胜生物与Osteopore签订口腔颌面产品在新加坡的独家代理协议
Apr 14, 2023 17:20 HKT |  |
|
億勝生物與Osteopore簽訂口腔頜面產品在新加坡的獨家代理協議
Apr 14, 2023 17:19 HKT | |
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
Apr 14, 2023 17:18 HKT | |
|
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies
Apr 12, 2023 19:30 HKT |  |
|
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies
Apr 12, 2023 19:30 HKT | |
|
金活醫藥授出股份獎勵提升團隊積極性 助力集團高速發展
Apr 11, 2023 15:42 HKT |  |
|
亿胜生物与郡是深圳签订皮耐克®可吸收性敷料在中国大陆的独家代理协议
Apr 11, 2023 13:00 HKT | |
|
億勝生物與郡是深圳簽訂皮耐克®可吸收性敷料在中國大陸的獨家代理協議
Apr 11, 2023 12:59 HKT | |
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
Apr 11, 2023 12:58 HKT | |
|
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50%
Apr 11, 2023 08:00 HKT |  |
|
Life Science Incubator Signs MOU with a strategic anchor tenant for its planned Brisbane Co-Working Laboratory Space Project
Apr 06, 2023 14:00 HKT |  |
|
Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Apr 05, 2023 18:00 HKT |  |
|
Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Apr 05, 2023 18:00 HKT | |
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Apr 04, 2023 17:00 HKT |  |
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Apr 04, 2023 17:00 HKT | |
|
沛嘉医疗2022年总收入按年升83.7%
Apr 03, 2023 14:54 HKT |  |
|